Investment in Potential


Cinclus Pharma

Cinclus Pharma is a Swedish clinical-stage pharma company developing small molecules for the treatment of gastric acid-related diseases. Our lead candidate linaprazan glurate is being developed for the treatment of moderate to severe gastroesophageal reflux disease (GERD).



DermView’s technology enables patients, hospitals and clinics to receive rapid, accurate diagnosis from leading Mohs1 surgeons, consultant dermatologists and plastic surgeons. It provides Ireland’s fastest route to access a Consultant Dermatologist diagnosis.


Aruna Bio

ArunA Bio is harnessing the natural abilities of neural exosomes to cross the blood brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders.



AniV8 (pronounced An-i-vate) is a company designed to become the leading developer of clinical sensor technology recommended by veterinarians to diagnose and monitor common animal disease states.



Qualus helps tanneries save costs, lower their environmental footprint and improve quality in leather production through the use of their patented technology, which uses polymer sferes to more effectively deliver chemicals into hides.


Sedana Medical

Sedana medical, a Swedish company, are the developers of the AnaConDa (Anaesthetic Conserving Device) which is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as Isoflurane or Sevoflurane to invasively ventilated patients.


Mirai Medical

Developer of medical devices designed to improve the outcome of cancer treatment. The company's technology has a unique IP that facilitates for painless delivery of electroporation energy endoscopically which greatly facilitates cancer treatment, enabling physicians to target tumors located anywhere on the body.

If you are interested in becoming an Investor or seeking investment, then please contact us.